Most patients with Acute Myeloid Leukaemia are treated with chemotherapy but this is successful only in a minority of cases. A plethora of novel agents are available but it is not known which drug will be best for which patient. The NUH haematology research team are seeking to develop same-day tests (called ‘dynamic profiling’) that will predict how a patient will respond to a specific drug. The NLA have contributed a grant of £5500 to this work which is aimed at giving the clinicians valuable information in the move towards personalised therapy.
Home » News » Nottingham University Hospitals research boosted by Nottinghamshire Leukaemia Appeal grant